Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hedera

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Journal of Central Nervous System Disease|January 4, 2014
Pharmacotherapy of essential tremorPeter Hedera, František Cibulčík, Thomas L Davis
BMC Neurology|July 20, 2013
Novel polymerase gamma (POLG1) gene mutation in the linker domain associated with parkinsonismRachel Dolhun, Erin M Presant, Peter Hedera
Neurology|May 14, 2020
Liver transplant for neurologic Wilson disease: Hope or fallacy?Oliver Bandmann, Karl Heinz Weiss, Peter Hedera
Brain Sciences|July 22, 2018
Novel Type of Complicated Autosomal Dominant Hereditary Spastic Paraplegia Associated with Congenital Distal Arthrogryposis Type IPeter Hedera, Paolo Moretti, Jane Howard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Autosomal recessive primary generalized dystonia in two siblings from a consanguineous familyPaolo Moretti, Peter Hedera, John Wald, et al.
The Journal of Clinical Investigation|September 21, 2013
REEPing the benefits of an animal model of hereditary spastic paraplegiaAriel Y Deutch, Peter Hedera, Roger J Colbran
Toxins|July 26, 2024
Role of Botulinum Toxin in Treatment of Secondary Dystonia: A Case Series and Overview of LiteratureDiksha Mohanty, Heather R M Riordan, Peter Hedera
Archives of Neurology|May 22, 2002
White matter changes in Wilson diseasePeter Hedera, George J Brewer, John K Fink
Brain Sciences|July 5, 2017
Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 MutationsDavid Isaacs, Daniel Claassen, Aaron B Bowman, et al.
Expert Opinion on Investigational Drugs|May 29, 2018
WTX101 - an investigational drug for the treatment of Wilson diseaseKarl Heinz Weiss, Anna Członkowska, Peter Hedera, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Journal of Central Nervous System Disease|January 4, 2014
Pharmacotherapy of essential tremorPeter Hedera, František Cibulčík, Thomas L Davis
BMC Neurology|July 20, 2013
Novel polymerase gamma (POLG1) gene mutation in the linker domain associated with parkinsonismRachel Dolhun, Erin M Presant, Peter Hedera
Neurology|May 14, 2020
Liver transplant for neurologic Wilson disease: Hope or fallacy?Oliver Bandmann, Karl Heinz Weiss, Peter Hedera
Brain Sciences|July 22, 2018
Novel Type of Complicated Autosomal Dominant Hereditary Spastic Paraplegia Associated with Congenital Distal Arthrogryposis Type IPeter Hedera, Paolo Moretti, Jane Howard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Autosomal recessive primary generalized dystonia in two siblings from a consanguineous familyPaolo Moretti, Peter Hedera, John Wald, et al.
The Journal of Clinical Investigation|September 21, 2013
REEPing the benefits of an animal model of hereditary spastic paraplegiaAriel Y Deutch, Peter Hedera, Roger J Colbran
Toxins|July 26, 2024
Role of Botulinum Toxin in Treatment of Secondary Dystonia: A Case Series and Overview of LiteratureDiksha Mohanty, Heather R M Riordan, Peter Hedera
Archives of Neurology|May 22, 2002
White matter changes in Wilson diseasePeter Hedera, George J Brewer, John K Fink
Brain Sciences|July 5, 2017
Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 MutationsDavid Isaacs, Daniel Claassen, Aaron B Bowman, et al.
Expert Opinion on Investigational Drugs|May 29, 2018
WTX101 - an investigational drug for the treatment of Wilson diseaseKarl Heinz Weiss, Anna Członkowska, Peter Hedera, et al.
Pageof 14